Novo Holdings Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 73
- Investments
- 492
- Portfolio
- 130
- Exits
- 198
Novo Holdings General Information
Description
Founded in 1999, Novo Holdings is a venture capital firm based in Copenhagen, Denmark. The firm prefers to invest in biotech, pharma, medtech, bioindustrials, and services.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
- Tuborg Havnevej 19
- 2900 Hellerup
- 2900 Copenhagen
- Denmark
+45 35 00 00 00
Novo Holdings Investments & Acquisitions (492)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Rondo Therapeutics | 02-Mar-2022 | Early Stage VC | 0000 | Biotechnology | Generating Revenue | |
| 00000000 | 28-Feb-2022 | 00000 00000 | 0000 | Building Products | Generating Revenue | 000000 00000 00.0 |
| 00000000 000000000 | 16-Feb-2022 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 0000000 000000 00.0 |
| 000 000000 | 15-Feb-2022 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 000000 0ø00000 |
| 0000000 000000000 | 02-Feb-2022 | 0000000000 | Media and Information Services (B2B) | Profitable | 00000000000 0ø0000000 | |
| 0000000000 | 21-Jan-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
| 000000 000000 | 14-Jan-2022 | 00000 00000 | 00000 | Media and Information Services (B2B) | Generating Revenue | 0000000 000 00 |
| 000000 | 04-Jan-2022 | 0000000000 | BPO/Outsource Services | Generating Revenue | ||
| The Ritedose | 04-Jan-2022 | Buyout/LBO | Pharmaceuticals | Profitable | 00000000 0000 | |
| 21st.Bio | 21-Dec-2021 | Early Stage VC | 000.00 | Biotechnology | Generating Revenue | 0ø000 000000 00.0 |
Novo Holdings Exits (198)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Syndesi Therapeutics | 01-Mar-2022 | Merger/Acquisition | 000 |
| 0000000 | 04-Feb-2022 | 000 | 00000 |
| 0000000 000000 | 13-Dec-2021 | 000000000000000000 | 00000 |
| 00 0000000 | 05-Nov-2021 | 000 | 00000 |
| 0000000 (000000000 | 26-Oct-2021 | 000 | 0000 |
| 0000000000 | 01-Oct-2021 | 000 | 00000 |
| 0000000 0000000000 | 15-Sep-2021 | 000 | 00000 |
| 000000 00000000000 | 18-Jun-2021 | 000 | 00000 |
| Verve Therapeutics | 17-Jun-2021 | IPO | 00000 |
| Thesan Pharmaceuticals | 24-May-2021 | Out of Business |
Novo Holdings Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialNovo Holdings Team (143)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Kasim Kutay | Chief Executive Officer | 0 | 0 | 0 | San Francisco, CA |
| Christoffer Søderberg | Managing Partner and Head of Principal Investments | 0 | 0 | 0 | Copenhagen, Denmark |
| Morten Beck Jørgensen | Managing Partner, Financial Investments | 0 | 0 | Copenhagen, Denmark | |
| Søren Moller Ph.D | Managing Partner, Novo Seeds | 00 | 0 | 0 | Copenhagen, Denmark |
| Scott Beardsley | Managing Partner, Novo Ventures (US) | San Francisco, CA |
Novo Holdings Co-Investors (438)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| RA Capital Management | 11 | 0 | 00 |
|
|
| OrbiMed | 0 | 00 |
|
|
|
| Rock Springs Capital | 0 | 0 |
|
|
|
| Vivo Capital | 0 | 0 | 0 |
|
|
| Citadel (Hedge Fund) | 0 | 0 |
|
|